Cargando…

Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy

This study aimed to evaluate the clinical outcomes of patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma (LSCC) treated with laryngectomy, and to assess the postoperative radiotherapy (PORT) results in terms of the survival of T3-T4aN0M0 patients with negative margins. This was a retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian, Heng, Yu, Yang, Yue, Zhu, Xiaoke, Zhou, Liang, Gong, Hongli, Xu, Chengzhi, Tao, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608082/
https://www.ncbi.nlm.nih.gov/pubmed/36311684
http://dx.doi.org/10.3892/ol.2022.13554
_version_ 1784818697817292800
author Zhou, Jian
Heng, Yu
Yang, Yue
Zhu, Xiaoke
Zhou, Liang
Gong, Hongli
Xu, Chengzhi
Tao, Lei
author_facet Zhou, Jian
Heng, Yu
Yang, Yue
Zhu, Xiaoke
Zhou, Liang
Gong, Hongli
Xu, Chengzhi
Tao, Lei
author_sort Zhou, Jian
collection PubMed
description This study aimed to evaluate the clinical outcomes of patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma (LSCC) treated with laryngectomy, and to assess the postoperative radiotherapy (PORT) results in terms of the survival of T3-T4aN0M0 patients with negative margins. This was a retrospective review of 369 T3-4aN0M0 glottic LSCC cases. The 5-year cancer-specific survival (CSS) and overall survival (OS) rates were 67.5 and 66.7%, respectively. Patients who received total laryngectomy had worse survival [5-year CSS, 62.5%; disease-free survival (DFS), 56.2%] than those who underwent partial laryngectomy (5-year CSS, 79.3%; DFS, 65.4%). More advanced-stage cancer is a predictor of poor survival. There was no significant difference in CSS or DFS between patients with positive margins following rescue therapy and those with negative margins. Furthermore, no difference in the survival rates was observed between patients with negative margins who received PORT and those who did not (5-year DFS: 59.1 vs. 63.8%, P=0.057 and CSS: 62.5 vs. 69.5%, P=0.074). For T3-4aN0M0 glottic LSCC patients, surgical treatment remained a good option, as it can achieve satisfactory oncological outcomes. However, PORT did not increase survival in surgically managed pT3-4aN0M0 LSCC patients with negative margins.
format Online
Article
Text
id pubmed-9608082
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-96080822022-10-28 Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy Zhou, Jian Heng, Yu Yang, Yue Zhu, Xiaoke Zhou, Liang Gong, Hongli Xu, Chengzhi Tao, Lei Oncol Lett Articles This study aimed to evaluate the clinical outcomes of patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma (LSCC) treated with laryngectomy, and to assess the postoperative radiotherapy (PORT) results in terms of the survival of T3-T4aN0M0 patients with negative margins. This was a retrospective review of 369 T3-4aN0M0 glottic LSCC cases. The 5-year cancer-specific survival (CSS) and overall survival (OS) rates were 67.5 and 66.7%, respectively. Patients who received total laryngectomy had worse survival [5-year CSS, 62.5%; disease-free survival (DFS), 56.2%] than those who underwent partial laryngectomy (5-year CSS, 79.3%; DFS, 65.4%). More advanced-stage cancer is a predictor of poor survival. There was no significant difference in CSS or DFS between patients with positive margins following rescue therapy and those with negative margins. Furthermore, no difference in the survival rates was observed between patients with negative margins who received PORT and those who did not (5-year DFS: 59.1 vs. 63.8%, P=0.057 and CSS: 62.5 vs. 69.5%, P=0.074). For T3-4aN0M0 glottic LSCC patients, surgical treatment remained a good option, as it can achieve satisfactory oncological outcomes. However, PORT did not increase survival in surgically managed pT3-4aN0M0 LSCC patients with negative margins. D.A. Spandidos 2022-10-19 /pmc/articles/PMC9608082/ /pubmed/36311684 http://dx.doi.org/10.3892/ol.2022.13554 Text en Copyright: © Zhou et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhou, Jian
Heng, Yu
Yang, Yue
Zhu, Xiaoke
Zhou, Liang
Gong, Hongli
Xu, Chengzhi
Tao, Lei
Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
title Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
title_full Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
title_fullStr Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
title_full_unstemmed Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
title_short Survival outcomes in patients with T3-4aN0M0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
title_sort survival outcomes in patients with t3-4an0m0 glottic laryngeal squamous cell carcinoma and evaluation of postoperative radiotherapy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608082/
https://www.ncbi.nlm.nih.gov/pubmed/36311684
http://dx.doi.org/10.3892/ol.2022.13554
work_keys_str_mv AT zhoujian survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy
AT hengyu survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy
AT yangyue survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy
AT zhuxiaoke survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy
AT zhouliang survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy
AT gonghongli survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy
AT xuchengzhi survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy
AT taolei survivaloutcomesinpatientswitht34an0m0glotticlaryngealsquamouscellcarcinomaandevaluationofpostoperativeradiotherapy